VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. AIG INSURANCE COMPANY OF CANADA

CourtDistrict Court, D. New Jersey
DecidedDecember 30, 2020
Docket3:18-cv-00493
StatusUnknown

This text of VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. AIG INSURANCE COMPANY OF CANADA (VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. AIG INSURANCE COMPANY OF CANADA) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. AIG INSURANCE COMPANY OF CANADA, (D.N.J. 2020).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

VALEANT PHARMACEUTICALS Civil Action No. 18-493 (MAS)(LHG) INTERNATIONAL, INC., et al.,

Plaintiffs,

v.

ORDER ON APPEAL AIG INSURANCE COMPANY OF FROM SPECIAL MASTER CANADA, et al.,

Defendants.

I. INTRODUCTION This matter comes before the Court by way of a partial appeal filed by Plaintiffs Valeant Pharmaceuticals International, Inc., Valeant Pharmaceuticals International, and AGMS, Inc. (collectively, “Plaintiffs”) of an Order entered by the Special Master appointed to assist with this case. [Docket Entry No. 213]. AIG Insurance Company of Canada, Allianz Global Risks US Insurance Company, Everest Insurance Company of Canada, Ironshore Canada Ltd., Lloyd’s Syndicate SJC 2003 and Temple Insurance Company (collectively, “Defendants” or “the insurers”) filed a Brief in Opposition (“Opposition”). [Docket Entry Nos. 219, 221]. Plaintiffs filed a Brief in Further Support of their partial appeal (“Reply”). [Docket Entry No. 226]. At the Court’s request, the parties supplemented the record on this appeal with a later-filed Joint Appendix. [Docket Entry No. 248]. The Court has considered the parties’ submissions without oral argument, pursuant to Fed. R. Civ. P. 78 and L. Civ. R. 78.1(b). II. BACKGROUND This is a complex breach of contract and declaratory judgment action in which Plaintiffs allege defendant insurance companies have improperly refused to provide coverage for the defense and settlement of a number of securities suits. Complaint at ¶1 [Docket Entry 1-1].1 The specific

policies at issue on this appeal contain a provision, referred to as Endorsement 18, which provides in pertinent part: [I]n the event that any of the statements, warranties or representations are not accurately and completely disclosed in the Application and such inaccurate or incomplete disclosure materially affects either the acceptance of the risk or the hazard assumed by the Insurer under the policy, no coverage shall be afforded for any Claim alleging, arising out of, based upon, attributable to or in consequence of the subject matter of any incomplete or inaccurate statements . . . .

Endorsement 18 (“Endorsement 18”), paragraph D excerpted from the Broad Form Management Liability Insurance Policy No. 01-714-68-05 that AIG Insurance Company of Canada issued to Valeant for the period from September 28, 2015 to September 28, 2016, attached as Exhibit A to the December 20, 2019 Certification of Sherilyn Pastor, Esq., in Support of Plaintiffs’ Partial Appeal [Docket Entry No. 213-3 at 60] (emphasis added). In this case, some of the insurers have relied upon Endorsement 18 to deny coverage, in light of what they claim was a material misrepresentation in the Application. Plaintiffs’ Memorandum of Law in Support of Plaintiffs’ Partial Appeal of the December 5, 2019 Opinion and Order of Special Master [Docket Entry No. 213-1] (“Appeal Brief”) at 1; Opposition at 1. The question on this appeal is whether Defendants must prove

1 A more detailed summary of the nature of this case has already been provided by the Court in its opinion deciding various Defendants’ Motions to Dismiss. Memorandum Opinion of the Honorable Michael A. Shipp, U.S.D.J., issued April 12, 2019 at pp. 2–6. [Docket Entry No. 195]. For purposes of this appeal, the Court only sets forth those facts necessary to an understanding of the decision. materiality under the contractual provision, and if so, whether Plaintiffs are entitled to certain underwriting materials in order to evaluate and challenge the insurers’ claim of materiality. On April 12, 2019, the Court appointed the Honorable Douglas K. Wolfson, J.S.C. (retired) (the “Special Master”) as Special Master in this matter (“Appointment Order”) [Docket Entry No.

197]. The Appointment Order empowered the Special Master to, inter alia, decide all pending and future discovery disputes. Id. ¶2a. It also provided that the undersigned would resolve any objections to the Special Master’s non-dispositive decisions. Id. ¶7. Pursuant to Paragraph 9 of the Appointment Order, appeals of findings of fact and conclusions of law are to be reviewed de novo, whereas non-dispositive issues are to be reviewed under an abuse of discretion standard. Id. On December 5, 2019, the Special Master issued the “Opinion of the Special Master on Production of Underwriting and Claims Manuals and Related Information” that decided a multitude of discovery disputes between the parties (the “Appealed Order” or the “Order”) [Docket Entry No. 212]. The issue on this appeal is only one of the many issues decided by the Special Master, namely whether Plaintiffs are entitled to discovery pertaining to procedures that “explain

and demonstrate the information Defendants themselves treat as material in assessing risk thresholds, setting the premium pricing, and issuing the policies (the ‘Procedures’).” Appealed Order at 3. In the Order, the Special Master distinguished between Plaintiffs’ attempts to seek Procedures documents from Defendants asserting a common law affirmative defense of misrepresentation from Plaintiffs’ attempts as to those asserting a defense based on an exclusion of coverage contained in Endorsement 18. Id. at 17–21. He concluded that the underwriting practices and policies constituted evidence of Defendants’ subjective beliefs, which are not material to the merits of the Exclusion 18 defense. Id. at 20. He also found that because “Valeant’s own restated public filing conclusively establishes a financial misrepresentation,” the Procedures documents would be irrelevant to the Endorsement 18 defense. Id. Ultimately, the Special Master granted Plaintiffs’ request to compel production of Procedures documents from Defendants asserting an affirmative defense of misrepresentation, id. at 25–26, but denied the request as to

Defendants asserting a contractual exclusion, id. at 20–21. Plaintiffs appeal the Order only insofar as it denied that portion of their motion. III. ARGUMENTS OF THE PARTIES A. Plaintiffs’ Appeal Plaintiffs argue that the denial of the discovery regarding materiality was erroneous in several respects. Appeal Brief at 9. First, they contend the Order erred by holding that a defense pursuant to Endorsement 18 does not require proof of materiality. Id. In this regard, Plaintiffs take issue with the distinction the Order drew between materiality as an element of a common law affirmative defense, and materiality in the context of a specific contractual undertaking, as in the case before the Court. Appeal Brief at 10–11.

Plaintiffs also challenge the Appealed Order’s reliance on Shapiro v. American Home Assurance Co., 584 F. Supp. 1245 (D. Mass. 1984) (“Shapiro”), which they distinguish on numerous grounds. Specifically, in Shapiro, the court considered the applicable Massachusetts rescission statute and the particular exclusion in that case rather than Endorsement 18, which contractually requires Defendants to establish materiality before denying coverage. Id. at 12. Plaintiffs argue that this language must be read narrowly in light of the parties’ intent to curtail the insurers’ ability to disclaim coverage. Id. at 11–12. In the motion and on appeal, Plaintiffs deny that they made any material misrepresentation at all, and dispute the facts asserted by Defendants. They acknowledge that Valeant made what they characterize as a “small restatement” to its financials but in no way concede the materiality of that restatement. Id. at 7. Next, Plaintiffs contend the Appealed Order improperly held that because materiality must be determined pursuant to an objective standard, the Procedures documents are irrelevant to a

materiality determination and are therefore not discoverable. Id. at 12–13.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Raddatz
447 U.S. 667 (Supreme Court, 1980)
Pahigian v. Manufacturers' Life Insurance
206 N.E.2d 660 (Massachusetts Supreme Judicial Court, 1965)
Lennon v. John Hancock Mutual Life Insurance
157 N.E.2d 518 (Massachusetts Supreme Judicial Court, 1959)
Shapiro v. American Home Assurance Co.
584 F. Supp. 1245 (D. Massachusetts, 1984)
Feldman v. Friedman
241 A.D.2d 433 (Appellate Division of the Supreme Court of New York, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. AIG INSURANCE COMPANY OF CANADA, Counsel Stack Legal Research, https://law.counselstack.com/opinion/valeant-pharmaceuticals-international-inc-v-aig-insurance-company-of-njd-2020.